| Study title |
HANMI: A Phase 2, Randomized, Double-Blind Study to Evaluate HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH; Protocol: HM-TRIA-201 |
| Disease or condition |
NAFLD/NASH with Fibrosis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
HM15211 or Placebo |
| Phase |
2 |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Ayako Suzuki, MD |
| Study coordinator |
Angela Braswell; angela.braswell@duke.edu |
| Phone contact |
(919) 668-2597 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04505436 |
